• Human SAN-Plexus Assembloids Model Neuro-Cardiac Pacemaker M

  2026-07-30

  This study introduces a human pluripotent stem cell-derived assembloid platform integrating sinoatrial node and cardiac plexus organoids, enabling functional analysis of neuro-cardiac interactions during pacemaker maturation. The model advances mechanistic understanding of neuron-to-pacemaker signaling and offers a new resource for studying conduction diseases.

• Pharmacokinetic Variability of CSBTA in MASH: Mechanisms and

  2026-07-29

  This study systematically dissects how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. By integrating transporter and enzyme expression profiles, the research provides actionable insights for optimizing preclinical models and dosing strategies relevant to metabolic liver disease.

• PORCN Inhibition with LGK-974 as a Therapeutic Avenue for Sc

  2026-07-29

  The referenced study demonstrates that pharmacological inhibition of Porcupine (PORCN) using LGK-974 can reduce excessive bone formation in sclerosteosis, a rare high bone mass disorder caused by SOST mutations. This work provides the first preclinical evidence for targeting Wnt signaling with a PORCN inhibitor to address severe skeletal overgrowth, offering a potential alternative to high-risk surgical interventions.

• Cefazedone (Refosporen): Mechanistic Insights for Translatio

  2026-07-28

  This article explores the mechanistic, experimental, and translational basis for deploying Cefazedone (Refosporen) in antibacterial research and clinical applications, with evidence-rich comparisons, protocol guidance, and forward-looking perspectives for translational scientists.

• SFRP1 Suppresses Wnt/β-Catenin Pathway in Oral Fibrosis Mode

  2026-07-28

  The referenced study elucidates how SFRP1 alleviates oral submucous fibrosis (OSF) by inhibiting the Wnt/β-catenin pathway and reducing neutrophil infiltration in an arecoline-induced mouse model. These findings establish a mechanistic foundation for targeting Wnt signaling in fibrotic oral disease and highlight SFRP1 as a potential modulator of fibrogenesis and immune cell dynamics.

• Thapsigargin: SERCA Pump Inhibitor for High-Fidelity ER Stre

  2026-07-27

  Thapsigargin, a potent SERCA pump inhibitor from APExBIO, empowers researchers to model calcium signaling and endoplasmic reticulum (ER) stress with unmatched precision. This guide offers actionable protocols, troubleshooting insights, and a critical synthesis of recent advances—helping labs drive reproducibility in apoptosis assays and neurodegenerative disease models.

• DAMGO: Precision µ-Opioid Receptor Agonist for Pain Models

  2026-07-27

  DAMGO empowers researchers to dissect central µ-opioid receptor signaling with unmatched specificity, enabling advanced pain model studies and tolerance mechanisms. Explore how its rigorous selectivity and well-characterized pharmacology translate into reproducible results, troubleshooting insights, and next-generation protocol refinement.

• Grazoprevir hydrate: Applied Workflows in HCV Replication In

  2026-07-26

  Grazoprevir hydrate (MK-5172 hydrate) delivers picomolar-scale inhibition of hepatitis C virus replication, empowering both preclinical and translational research. This article details robust experimental workflows, advanced use cases, and troubleshooting strategies that leverage APExBIO’s trusted product for high-fidelity HCV studies.

• Fenofibrate and the PPARα-YAP Axis: New Frontiers in Aging L

  2026-07-25

  Explore how Fenofibrate, a potent PPARα agonist, reveals novel insights into age-independent liver enlargement and metabolic regulation. This article uniquely examines assay design, the mechanistic interplay with YAP signaling, and practical considerations for aging models.

• Y-27632 in Neurodegeneration: Precision ROCK Inhibition and

  2026-07-24

  Explore how the selective ROCK inhibitor Y-27632 enables advanced research into cytoskeletal dynamics and neurodegenerative mechanisms. This article uniquely bridges molecular pharmacology with STMN2 regulation, expanding the utility of Y-27632 beyond conventional workflows.

• Naloxone Hydrochloride in Neural and Immune Modulation Resea

  2026-07-24

  Explore the multifaceted role of naloxone hydrochloride as an opioid receptor antagonist in neural stem cell and immune modulation research. This article offers advanced mechanistic insights and practical guidance, distinguishing itself with a critical analysis of cross-domain implications.

• D-Luciferin Potassium Salt: Optimizing In Vivo Imaging Workf

  2026-07-23

  D-Luciferin (potassium salt) is the gold-standard substrate for precise, real-time in vivo bioluminescence imaging and luciferase assays. Its superior water solubility and purity, as offered by APExBIO, empower sensitive, reproducible tumor and stem cell tracking while streamlining experimental workflows in preclinical research.

• Tubastatin A Mitigates Myocardial Injury After Cardiac Arres

  2026-07-23

  This study demonstrates that Tubastatin A, a selective HDAC6 inhibitor, reduces myocardial damage following resuscitation from cardiac arrest in a porcine model. The findings highlight the compound's ability to suppress GSDME-mediated pyroptosis and MLKL-mediated necroptosis, offering new mechanistic insights for post-resuscitation cardiac protection.

• Grazoprevir Hydrate: Advanced HCV Replication Inhibition Wor

  2026-07-22

  Grazoprevir hydrate (MK-5172 hydrate) is a gold-standard HCV NS3/4A protease inhibitor, enabling high-fidelity hepatitis C virus replication inhibition across genotypes and patient backgrounds. Explore robust experimental protocols, troubleshooting strategies, and real-world applications that maximize its value in both translational and therapeutic HCV research.

• Talabostat Mesylate (PT-100): Precision DPP4/FAP Inhibition

  2026-07-22

  Talabostat mesylate (PT-100) empowers targeted modulation of the tumor microenvironment by specifically inhibiting DPP4 and FAP, pivotal in cancer immunology and stromal biology. This guide details optimized workflows, troubleshooting strategies, and experimental innovations that leverage Talabostat mesylate for advanced tumor research.

8537 records 10/570 page Previous Next First page 上5页 678910 下5页 Last page